E

EvergreenHealth | Kirkland, WA

Research site

(Unclaimed)

Location

12034 NE 128th Street, Kirkland, Washington, United States of America

Site insights

Top conditions

Top treatments

RPC1063

BIIB080

Ozanimod

NEU-411

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

Locations recently updated

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease (NEULARK)

The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 50-80 years with early Parkinson's...

Enrolling

Idiopathic Parkinson Disease

Early Parkinson Disease (Early PD)

Other: Placebo

Drug: NEU-411

A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA)

In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...

Active, not recruiting

Mild Cognitive Impairment Due to Alzheimer's Disease

Alzheimer's Disease Dementia

Drug: BIIB080-matching placebo

Drug: BIIB080